Mentions
Extended reach
Total likes
Video views
AI synopsis
Multiple posts highlight the increased risk of type 2 diabetes associated with steroid 5α-reductase inhibitors, using phrases like 'spoiler alert' and 'potential development,' which demonstrate both curiosity and concern. The tone varies from casual mentions to more analytical reflections, contributing to a moderate overall perception of impact and depth of engagement in understanding the research's significance.
Most discussions acknowledge the study's findings of an increased diabetes risk with certain medications, indicating moderate agreement or acceptance of the results.
The majority of posts show high curiosity, with many referencing specific details like 'spoiler alert: increased risk' or mentioning the study's implications for long-term treatment options, suggesting strong engagement.
Posts include references to related research, discussions on the implications of the findings, and some sharing of personal or professional opinions, reflecting a moderate to deep level of engagement.
While some acknowledge the importance of the findings, posts generally view it as a noteworthy development rather than a paradigm shift, indicating a perception of moderate impact.
Nice to see our paper published in BMJ. Great work @RuthAndrewMSEd and @BWalker1963 and the team on a great project. @School_Pharmacy Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/ZYCKdfrg6j
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/KJ9APfVf23
2) this study from Taiwan discusses potential development of Type 2 diabetes. Do long term BPH meds make sense for QOL disorder ? https://t.co/p21TaRb3sX @MountsinaiUro @medivizor @UrologyTimes @JUrology
アボルブなどの5α-還元酵素阻害薬はタムスロシンよりも2型糖尿病リスクになるかもしれない Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study. - PubMed - NCBI https://t.co/LanLjIDZ3Y
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/nIxl8VF1p6 SPOILER ALERT: increased risk
https://t.co/0VWNiIxHXr
This video explores how steroid 5-alpha reductase inhibitors like dutasteride and finasteride may increase the risk of developing type 2 diabetes in men, based on population studies from the UK and Taiwan. Understand…
Men taking steroid 5-reductase inhibitors like dutasteride or finasteride for benign prostatic hyperplasia show a modestly increased risk of developing type 2 diabetes, based on population studies from the UK and Taiwan.
https://t.co/0VWNiIxHXr
Incidence of Type 2 Diabetes Mellitus in Men Receiving Steroid 5α-Reductase Inhibitors https://t.co/Rqj4PUB5fY
Incidence of Type 2 Diabetes Mellitus in Men Receiving Steroid 5α-Reductase Inhibitors https://t.co/YRNPcXKeZp
"Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study" https://t.co/xBAJWMn29H
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/3DLS1L55Um
RT @dravinashsingh: Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study h…
RT @dravinashsingh: Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study h…
RT @ariosvaca: Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https:…
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/nIxl8VF1p6 SPOILER ALERT: increased risk
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/rMQAU8SNIP @MaleHealthDoc
アボルブなどの5α-還元酵素阻害薬はタムスロシンよりも2型糖尿病リスクになるかもしれない Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study. - PubMed - NCBI https://t.co/LanLjIDZ3Y
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/PjEQxMczni
RT @MaleHealthDoc: 2) this study from Taiwan discusses potential development of Type 2 diabetes. Do long term BPH meds make sense for QOL…
2) this study from Taiwan discusses potential development of Type 2 diabetes. Do long term BPH meds make sense for QOL disorder ? https://t.co/p21TaRb3sX @MountsinaiUro @medivizor @UrologyTimes @JUrology
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors… https://t.co/vUiYizQwax
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study | The BMJ https://t.co/UJWiThOYRL
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/SVgJ7tnLiN
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study. https://t.co/XfjMXG3XD3
RT @LiWeiUCL: Nice to see our paper published in BMJ. Great work @RuthAndrewMSEd and @BWalker1963 and the team on a great project. @School_…
RT @LiWeiUCL: Nice to see our paper published in BMJ. Great work @RuthAndrewMSEd and @BWalker1963 and the team on a great project. @School_…
Nice to see our paper published in BMJ. Great work @RuthAndrewMSEd and @BWalker1963 and the team on a great project. @School_Pharmacy Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/ZYCKdfrg6j
RT @AmarPut: Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://…
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/SfDDdITl93
RT @Ray_Noble1: Incidence of type 2 diabetes mellitus in men receiving steroid 5{alpha}-reductase inhibitors: population based cohort study…
RT @Ray_Noble1: Incidence of type 2 diabetes mellitus in men receiving steroid 5{alpha}-reductase inhibitors: population based cohort study…
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/KJ9APfVf23
[OA] Incidence of Type 2 Diabetes Mellitus in Men Receiving Steroid 5α-Reductase Inhibitors Objective To investigate the incidence of new onset type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors (dutasteride or... https://t.co/qmEAAWvcXG
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/Z1lw8pLMMo
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/0in9XAKWmp
#bmj Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study https://t.co/BnCBNF1mkL
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population ... https://t.co/anpbXfLJBf
Incidence of type 2 diabetes mellitus in men receiving steroid 5{alpha}-reductase inhibitors: population based cohort study https://t.co/mCSIRkj0qb
Incidence of type 2 diabetes mellitus in men receiving steroid 5{alpha}-reductase inhibitors: population based cohort study https://t.co/5tmPudnFAl https://t.co/Xx3dK17gD7
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study - The BMJ https://t.co/sMoXd6jV3C https://t.co/UuDl5FTZ6H
Incidence of type 2 diabetes mellitus in men receiving steroid 5{alpha}-reductase inhibitors: population based cohort study https://t.co/Q7GHAxKqky https://t.co/xrzcIF7e31
Incidence of type 2 diabetes mellitus in men receiving steroid 5{alpha}-reductase inhibitors: population based cohort study https://t.co/TnZvIFEZFR https://t.co/XyGKQxnwNd